Broken String Biosciences is a genomics company that is building a technology platform to drive the development of cell & gene therapies that are safer by design. Here are details of Broken String Biosciences’s latest funding round :
Felix Dobbs, Simon Reed, Simon Kerr, Vincent Smith, Jessica Rich, Patrick van Eijk, Anthony Underwood, Sam Huguet
💸 Funding & Investors
- Investment (September 2023) : €14 million (Series A). In September 2021, it secured nearly $4M in a Series Seed round from investors across the UK, Germany, and the US.
- Investors : co-led by Illumina Ventures and Mérieux Equity Partners, with contributions from HERAN Partners and participation from existing investors Tencent and Dieter von Holtzbrinck Ventures.
🎯 Funding purpose
Product development, growth and expansion in the US.
🌐 Country HQ